This information was published on 2021-04-16T08:53:42 for IP Right Registration Published.
| Field | Value |
| (210) | 2147535 (IR 1569623) |
| (220) |
29 Sep 2020
|
| (300) |
US, 31 Jul 2020, 90086563
|
| (511) (510) |
Class 5
Pharmaceutical preparations, namely, medications for the treatment of ischemic stroke, hemorrhagic stroke, transient ischemic attack, alzheimer's disease, parkinson's disease, mixed dementia, frontotemporal dementia, dementia with lewy bodies, vascular dementia, wernicke-korsakoff syndrome, huntington's disease, creutzfeldt jakob disease, normal pressure hydrocephalus, spinal cord injury, traumatic brain injury, amyotrophic lateral sclerosis, multiple sclerosis, hypoxic-ischemic injury to the brain or spinal cord and neurodegenerative diseases. |
| (540) | PHARMAZZ |
| (550) | Word |
| (730) |
PHARMAZZ, INC.
|
Find out more about publications on the About page.